(Q42656427)

English

Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients

scientific article published on February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients (English)

1 reference

Europe PubMed Central

4 November 2017

1 reference

based on heuristic

inferred from title

12

object named as

E Steve Woodle

1 reference

Europe PubMed Central

4 November 2017

author name string

William Robert Morrow

1

1 reference

Europe PubMed Central

4 November 2017

Elizabeth A Frazier

2

1 reference

Europe PubMed Central

4 November 2017

William T Mahle

3

1 reference

Europe PubMed Central

4 November 2017

Terry O Harville

4

1 reference

Europe PubMed Central

4 November 2017

Sherry E Pye

5

1 reference

Europe PubMed Central

4 November 2017

Kenneth R Knecht

6

1 reference

Europe PubMed Central

4 November 2017

Emily L Howard

7

1 reference

Europe PubMed Central

4 November 2017

R Neal Smith

8

1 reference

Europe PubMed Central

4 November 2017

Robert L Saylors

9

1 reference

Europe PubMed Central

4 November 2017

Xiomara Garcia

10

1 reference

Europe PubMed Central

4 November 2017

Robert D B Jaquiss

11

1 reference

Europe PubMed Central

4 November 2017

language of work or name

0 references

publication date

1 February 2012

1 reference

Europe PubMed Central

4 November 2017

Transplantation

1 reference

Europe PubMed Central

4 November 2017

93

1 reference

Europe PubMed Central

4 November 2017

3

1 reference

Europe PubMed Central

4 November 2017

319-324

1 reference

Europe PubMed Central

4 November 2017

Management of allosensitized cardiac transplant candidates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Proteasome inhibition for antibody-mediated rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Acute antibody-mediated rejection of cardiac transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Pediatric cardiac transplantation in children with high panel reactive antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Preformed anti-human leukocyte antigen antibodies jeopardize cardiac transplantation in patients with a left ventricular assist device

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Outcome of cardiac transplant recipients with a positive donor-specific crossmatch--preliminary results with plasmapheresis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

27 May 2018

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

Survival in allosensitized children after listing for cardiac transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

C4d deposition in cardiac allografts correlates with alloantibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

HLA alloimmunization in patients requiring ventricular assist device support.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730122

16 August 2018

The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22179403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22179403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22179403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of rituximab to decrease panel-reactive antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22179403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22179403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of plasmapheresis for acute humoral rejection after heart transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22179403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of vascular rejection with rituximab in cardiac transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22179403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/TP.0B013E31823F7EEA

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42656427&oldid=2069662240"